Science & Tech — VisionIAS Mains-365 Condensed Notes

OVERVIEW & PURPOSE

  • VisionIAS “Mains-365 Science & Technology” summary distils current‐affairs content for UPSC-Mains preparation.

  • Coverage spans:

    • IT, Computers & Robotics

    • Biotechnology, Nanotechnology & IPR

    • Space Science & Applications

    • Health & Medicine

    • Miscellaneous Emerging Technologies

  • Each sub-section below captures: context/Why-in-News, core concepts, applications, national & global initiatives, challenges, ethical / socio-economic implications, statistical references, and way-forward.

IT, COMPUTERS & ROBOTICS

  • International Year of Quantum Science & Technology

    • UN declared 2025 (marking 100 yrs of Heisenberg’s breakthrough).

    • Key use-cases: Quantum Key Distribution, high-precision sensing, simulation for drug discovery/material design.

    • Indian ecosystem: National Quantum Mission 2023, QuEST, QCAL, NMQTA.

    • Challenges: regulation vacuum, extreme cryogenic cooling, scalability, infrastructure cost, low R&D spend \approx0.64\% GDP.

  • Brain–Computer Interfaces (BCIs)

    • Neuralink’s “Blindsight’’ FDA ‘breakthrough device’ status to restore vision.

    • BCIs acquire CNS signals → translate into commands.

    • Types: Invasive, Partially-invasive (ECoG), Non-invasive (EEG).

    • Applications: neuro-prosthetics, wellness, cognitive enhancement, gaming.

    • Concerns: infection, data privacy, ‘stimuli attacks’, cyborgisation ethics.

    • Indian support: amended New Drugs & Clinical Trials Rules 2019, Phenome-India, ICGA.

  • Organ-on-Chip (OoC)

    • 1.4\,\text{billion\$} market by 2032; pillar of “BioE^3” – Biotechnology for Economy, Environment, Employment.

    • Micro-fluidic chips + living tissues + drug-delivery cues + real-time sensors.

    • Advantages over animal/2-D culture: precision therapeutics, human physiology mimicry.

  • Nobel Prize in Physics 2024

    • John Hopfield (Hopfield network) & Geoffrey Hinton (Boltzmann machine); laid foundation of modern artificial neural networks.

  • Deepfakes

    • AI-synthesised audio/video/images; US “Take It Down Act’’; Indian redress via IT Act 2000, IT Rules 2021, I4C.

    • Risks: national security, democratic trust, non-consensual abuse.

    • Mitigation: proactive regulation, detection tech (MIT Detect Fakes), cyber-literacy.

  • Big Data

    • India joined UN-CEBD.

    • Defined as datasets whose volume/velocity/variety demand novel architecture.

    • Use-cases: logistics (Swiggy), OTT (Netflix), smart-cities, earth-sciences.

    • Bottlenecks: real-time analytics, skilled manpower, GDPR-type compliance.

  • Supercomputers

    • PARAM Rudra & new HPC for weather launched under National Super-computing Mission.

    • Performance metric FLOPS; earliest PARAM 8000 1991; AIRAWAT ranked 75^{th} 2023.

    • Issues: energy, cooling, semiconductor import-dependency.

    • Path: domestic fab (India Semi-mission), green HPC.

  • 4\text{D} Printing

    • 3-D object + time; stimulus-responsive shape-shift.

    • IIT team printed artificial blood vessels.

    • Sectors: soft-robotics, aerospace (Nitinol), drug-delivery.

BIOTECHNOLOGY, NANOTECHNOLOGY & IPR

  • Genetically Modified Organisms (GMO)

    • Draft amended Hazardous Micro-Organism Rules 2024.

    • Techniques: Gene-gun, Agrobacterium, Electroporation, Micro-injection.

    • Indian status: Bt-cotton 2002; Bt-brinjal moratorium 2009; GM mustard (DMH-11) cleared but not commercialised.

    • Concerns: ecological spill-over (Monarch butterflies), seed sovereignty, IP monopoly.

  • RNA Editing

    • First clinical proof-of-concept.

    • ADAR converts adenosine \rightarrow inosine on mRNA → reversible vs permanent DNA-CRISPR.

  • Nobel Prize in Medicine 2024

    • Victor Ambros & Gary Ruvkun: micro-RNA discovery (post-transcriptional gene regulation).

    • miRNA roles: development, immunity, oncogenesis, diagnostics.

  • Mitochondrial Transplantation

    • Moving healthy mitochondria to diseased cells (Parkinson, infertility, heart failure).

    • Challenges: cold-storage limits, immune rejection, germline ethics.

  • Nobel Prize in Chemistry 2024

    • David Baker (computational protein design – Top7), Demis Hassabis & John Jumper (AlphaFold protein-fold prediction).

  • Recombinant Proteins

    • IISc developed scalable process (Pichia pastoris).

    • Applications: insulin, vector-vaccines, GM feed, bioremediation.

  • Graphene

    • 2004 discovery; 2010 Nobel.

    • Properties: 200\times stronger than steel yet \frac16 weight; 2.3\% light absorption; impermeable to gases; quantum Hall.

    • Indian thrust: India Graphene Engineering & Innovation Centre (IGEIC); Graphene-Aurora program.

SPACE SCIENCE & APPLICATIONS

  • Axiom-4 Mission

    • First ISS government-sponsored flights for India, Poland, Hungary >40 yrs.

    • Indian payloads: microgravity crop growth, cyanobacteria, tardigrades.

    • Inputs for Gaganyaan (crewed LEO 400\,\text{km}, 3 days).

  • Bharatiya Antariksh Station (BAS)

    • 400–450\,\text{km} orbit; 5 modules; base-module launch 2028; full 2035.

  • Space Docking Experiment (SPaDeX)

    • Indigenous autonomous rendezvous of chaser & target cubesats at 700\,\text{km}, \approx28\,000\,\text{km/h}.

  • Third Launch Pad

    • Approved for Sriharikota; supports NGLV & upgraded LVM-3 (semi-cryogenic stage); \approx4 yrs completion.

  • Engine Technologies

    • Scramjet: DRDL 120\,\text{s} active-cool test; needs rocket boost to hypersonic (>\text{Mach} 3).

    • CE-20 Cryogenic: LPSC; powers LVM-3 upper stage (Chandrayaan-3, OneWeb).

    • Cryo uses LH_2 at -253^\circ\text{C} & LOX -183^\circ\text{C} → high Isp, eco-friendly (water vapour).

  • Aditya-L1

    • 7 payloads; halo-orbit around Sun–Earth L_1; imaged solar-flare kernel.

  • Hyperspectral Imaging constellation “Firefly’’ (Pixxel)

    • 6 private satellites → tree-level spectral fingerprinting.

  • Outer Space Governance

    • Artemis Accords (launched 2020, now 55 signatories inc. India).

    • Issues: 130\,\text{million} debris pieces; resource extraction norms; traffic mgmt.

    • UN recommendations: new treaty, debris-removal, inclusive stakeholder framework.

  • Space Debris

    • Starship explosion spread fragments over Florida/Bahamas.

    • Mitigation: IADC, UN guidelines, ISRO–NETRA, IS4OM, “Zero-Debris Charter’’ (12 nations).

  • Space-Based Surveillance (SBS-3)

    • CCS okayed comprehensive land-sea-air EO constellation; builds on SBS-1 (2001), SBS-2 (2013).

  • NavIC

    • 7 sats ( 3 GSO + 4 IGSO) S-band & L5; 1500\,\text{km} beyond borders; used in Op. Sindoor.

  • Satellite Internet

    • Starlink licensed 5 yrs; other constellations: OneWeb, Kuiper, China’s Qianfan.

    • Issues: latency, secure use (terrorists), ozone depletion, e-waste.

  • Ladakh Observatory Hub

    • MACE Cherenkov telescope (world 2^{nd} largest) inaugurated at Hanle; region ideal Mars/Moon analogue.

  • Black-Hole Merger

    • Largest masses detected via gravitational waves; furthers tests of General Relativity & stellar evolution.

  • Geomagnetic Storms

    • G5 storm struck Earth after 20 yrs; driven by CMEs & solar flares; threats to grid, GNSS, airlines.

  • Meteorite Fall (Beed, Maharashtra)

    • Provides primordial clues to solar-system composition; India collaborating via All-Sky Fireball Network.

HEALTH & MEDICINE

  • Trans-Fat Elimination

    • WHO milestone report 2018–2023: policy cover rose 6\%\to46\% of world pop.; 2023 target unmet.

    • India: FSSAI cap 2\% TFA; “Heart Attack Rewind’’; REPLACE framework.

  • Obesity

    • PM highlighted 1/8 people obese; NFHS-5: women 24\%, men 23\%; children <5 yrs overweight 3.4\%.

  • Anti-Microbial Resistance (AMR)

    • UN declaration aims 10\% mortality reduction by 2030; calls \$100\,\text{m} funding.

    • India risk: 2\,\text{million} deaths / year by 2050.

    • Environment (Protection) Rules 2019 limit 121 antibiotic residues in effluent.

  • Zoonotic Diseases

    • IDSP 2018–2023: 8.3\% outbreaks zoonotic; Japanese Encephalitis 29.5\% of them; NE India hotspot.

  • Drug Quality

    • CDSCO recalled 49 drugs; only \approx2\,000/10,500 units WHO-GMP compliant; SSDRS scheme strengthening labs.

  • Fixed-Dose Combinations

    • 35 FDCs banned; pros: pill-burden, cost; cons: dose-inflexibility, AMR, unapproved exports.

  • CAR-T Therapy

    • India’s first indigenous product launched; autologous T-cells engineered with chimeric receptor.

  • Oral Rehydration Therapy

    • Inventor Richard Cash passed; ORS + zinc lowered under-five diarrhoeal deaths by \approx67\% since 1990.

  • Pandemic Agreement (WHA 2024)

    • Aligns with IHR 2005; sets Pathogen Access & Benefit Sharing (firms give WHO 20\% of output).

  • Non-Communicable Diseases

    • NCDs cause 74\% global, 63\% Indian deaths; intensified screening launched; aims SDG 3.4 one-third mortality cut.

  • Tuberculosis

    • New 6-month BPaLM (Bedaquiline Pretomanid Linezolid Moxifloxacin) for MDR-TB vs old 20 mths; India TB cases 25.52\,\text{lakh} 2023.

  • Neglected Tropical Diseases

    • WHO 2024 report: target 90\% reduction people needing interventions by 2030; India holds 40\% global NTD burden.

  • Rare Diseases

    • CDSCO okayed first anti-complement therapy; NPRD 2021 groups 63 rare diseases; treatment gaps – 95\% have none; under-utilised CoE funds 47/71\,\text{crore}.

MISCELLANEOUS EMERGING TECHNOLOGIES

  • Pressurised Heavy Water Reactors

    • North India’s first PHWR at Gorakhpur; 2\times700\,\text{MW} units.

  • Fast Breeder Reactor

    • 500\,\text{MWe} PFBR at Kalpakkam commissioning by 2026 → Stage-2 of 3-stage nuclear program.

  • Thorium-Molten Salt Reactor

    • China’s first grid-connected reactor 2025; India rich in monazite 8–10\% Th in Kerala sands.

  • Small Modular Reactors / Bharat Small Reactors

    • Capacity \le300\,\text{MW}_e; budget 2024 announced PPP; benefits: passive safety, modular factory build; issues: cost-per-MW, HALEU fuel.

  • Tokamak Fusion – ITER

    • Central solenoid completed; 30+ nations; India via Institute for Plasma Research.

  • Sodium-Ion Batteries

    • Lab cell: 80\% charge in 6 min, >3,000 cycles; 15–20\% cheaper vs Li-ion, decentralised supply.

  • Hyperloop

    • IIT-Madras & TuTr built 410\,\text{m} test-track; theoretical 1200\,\text{km/h}; vacuum maintenance & passenger g-forces key hurdles.

  • Desalination

    • IIT-Bombay lotus-leaf graphene evaporator; comparison: Thermal (LT-MED in Lakshadweep) vs Membrane (Nemmeli RO).

  • Light Supersolid

    • CNR-Italy created polariton supersolid, bridging photonics & quantum matter → stable qubits, photonic circuits.

  • Vigyan Dhara Scheme

    • Clubbing three MoST umbrella schemes 2021–2026; aims human-resource pool, FTE researcher rise & gender parity.

CROSS-CUTTING ETHICAL & PRACTICAL CONSIDERATIONS

  • Privacy & Data Ownership (Deepfakes, BCIs, Big-Data).

  • Dual-Use & Militarisation (Quantum, NavIC, Space-based Surveillance, Gene-editing).

  • Environmental Sustainability (Graphene production, Cryogenic fuels, Space Debris, Desalination brine).

  • Inclusive Access & Equity (Pandemic treaty PABS, Trans-fat elimination, Rare-disease funding, Hyperloop affordability).

  • Indigenous Capability vs Global Partnerships (BAS, SMRs, Fast Breeder, ITER, Axiom).

QUICK-RECALL FORMULAE & DEFINITIONS

  • Body Mass Index =\dfrac{\text{Weight (kg)}}{[\text{Height (m)}]^2}

  • Solar Storm Severity: G1\text{ (Minor)}\ldots G5\text{ (Extreme)}

  • Lagrange Points: \nabla V =0 in rotating reference frame → L1 \ldots L5.

  • Haber’s law (toxicology) context AMR waste C\times t = k (constant effect).

REVISION TIPS

  • Correlate tech with SDG targets (e.g.

    • SDG-3 health ↔ CAR-T, AMR, NTDs;

    • SDG-7 clean energy ↔ SMR, Fusion, Sodium-Ion Battery;

    • SDG-9 innovation ↔ Quantum, Graphene, 4D-printing).

  • Integrate ethical viewpoints: utilitarian benefit vs deontological rights (Deepfakes, Gene-editing).

  • Use Indian constitutional hooks: Art 21 (privacy, health) for Deepfakes & drug quality; DPSP Art 48A for clean environment (Space debris, desalination).

CONCLUSION

Mastery over these developments—technical details + governance dimensions—will enrich UPSC answers with depth, policy linkage, and futuristic insight.